Variant Angina is Associated with Myocarditis

References

• Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris I. A variant form of angina pectoris. Am J Med. 1959;27(3):375–388. doi:10.1016/0002-9343(59)90003-8
   PubMed Web of Science ®Google Scholar
• Pol D, Sethwala A, Wynn G. Severe vasospastic angina causing total coronary occlusion. Eur Heart J. 2020;41(37):3590. doi:10.1093/eurheartj/ehaa368
   PubMed Web of Science ®Google Scholar
• Bil J, MoZeNska O, Segiet-SwiEcicka A, Gil RJ. Revisiting the use of the provocative acetylcholine test in patients with chest pain and nonobstructive coronary arteries: a five-year follow-up of the AChPOL registry, with special focus on patients with MINOCA. Transl Res. 2021;231:64–75. doi:10.1016/j.trsl.2020.11.009
   PubMed Web of Science ®Google Scholar
• Cho -S-S, Jo S-H, Han SH, et al. Clopidogrel plus aspirin use is associated with worse long-term outcomes, but aspirin use alone is safe in patients with vasospastic angina: results from the VA-Korea Registry, A prospective multi-center cohort. Sci Rep. 2019;9(1). doi:10.1038/s41598-019-54390-w.
   Web of Science ®Google Scholar
• Oh MS, Yang JH, Lee DH, et al. Impact of statin therapy on long-term clinical outcomes of vasospastic angina without significant stenosis: a propensity-score matched analysis. Int J Cardiol. 2016;223:791–796. doi:10.1016/j.ijcard.2016.08.229
   PubMed Web of Science ®Google Scholar
• Bussolino F, Breviario F, Tetta C, Aglietta M, Mantovani A, Dejana E. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest. 1986;77(6):2027–2033. doi:10.1172/JCI112532
   PubMed Web of Science ®Google Scholar
• Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs. 1991;42(1):9–29. doi:10.2165/00003495-199142010-00002
   PubMed Web of Science ®Google Scholar
• Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol. 2006;110(1):7–14. doi:10.1016/j.ijcard.2005.08.007
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. J Clin Invest. 1996;97(3):769–776. doi:10.1172/JCI118476
   PubMed Web of Science ®Google Scholar
• Ohyama K, Matsumoto Y, Takanami K, et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol. 2018;71(4):414–425. doi:10.1016/j.jacc.2017.11.046
   PubMed Web of Science ®Google Scholar
• Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc. 2012;7(5):872–881. doi:10.1038/nprot.2012.024
   PubMed Web of Science ®Google Scholar
• Toyo-Oka T, Aizawa T, Suzuki N, et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991;83(2):476–483. doi:10.1161/01.CIR.83.2.476
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Nakamura M. Histamine-induced spasm not significantly modulated by prostanoids in a swine model of coronary artery spasm. J Am Coll Cardiol. 1985;6(2):321–327. doi:10.1016/S0735-1097(85)80167-4
   PubMed Web of Science ®Google Scholar
• Hirota Y, Nakamori S, Hiramatsu D, Moriwaki K, Imanaka-Yoshida K, Dohi K. Pathological Q-waves with coronary artery spasm. JACC Case Rep. 2021;3(4):555–560. doi:10.1016/j.jaccas.2020.11.033
   PubMedGoogle Scholar
• Sheibani H, Javedani Masroor M. Pericarditis as a trigger for prinzmetal angina - a case report. J Med Life. 2021;14(6):853–861. doi:10.25122/jml-2021-0061
   PubMedGoogle Scholar
• Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ 2nd, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med. 1985;313(18):1138–1141. doi:10.1056/NEJM198510313131807
   PubMed Web of Science ®Google Scholar
• Klein RM, Schwartzkopff B, Strauer BE. Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemically proven myocarditis. Am Heart J. 1998;136(3):389–397. doi:10.1016/S0002-8703(98)70211-X
   PubMed Web of Science ®Google Scholar
• Schonau V, Vogel K, Englbrecht M, et al. The value of (18) F-FDG-PET/CTin identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77:70–77. doi:10.1136/annrheumdis-2017-211687
   PubMed Web of Science ®Google Scholar
• Nihei T, Takahashi J, Hao K, et al. Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina. Eur Heart J. 2018;39(11):952–959. doi:10.1093/eurheartj/ehx657
   PubMed Web of Science ®Google Scholar
• Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci. 2007;104(2):109–115. doi:10.1254/jphs.CP0070027
   PubMed Web of Science ®Google Scholar
• Lin YK, Yeh CT, Kuo KT, et al. Apolipoprotein (a)/Lipoprotein(a)-Induced oxidative-inflammatory alpha7-nAChR/p38 MAPK/IL-6/RhoA-GTP signaling axis and M1 macrophage polarization modulate inflammation-associated development of coronary artery spasm. Oxid Med Cell Longev. 2022;2022:9964689. doi:10.1155/2022/9964689
   PubMed Web of Science ®Google Scholar
• Hung MY, Wu YH, Bamodu OA, et al. Activation of the monocytic alpha7 nicotinic acetylcholine receptor modulates oxidative stress and inflammation-associated development of coronary artery spasm via a p38 MAP-kinase signaling-dependent pathway. Free Radic Biol Med. 2018;120:266–276. doi:10.1016/j.freeradbiomed.2018.03.050
   PubMed Web of Science ®Google Scholar
• Dejana E, Ji-Ming W, Mantovani A. The recruitment of leukocytes and their interaction with the vessel wall: the role of interleukin-1 and tumor necrosis factor. Scand J Rheumatol Suppl. 1987;66:19–25. doi:10.3109/03009748709102518
   PubMedGoogle Scholar
• Figueras J, Garcia-Dorado D, Agullo L, et al. Activation of polymorphonuclear leukocytes and increased plasma vasoconstrictors in vasospastic and nonvasospastic angina. Can J Cardiol. 2011;27(5):601–605. doi:10.1016/j.cjca.2011.01.004
   PubMed Web of Science ®Google Scholar
• Park JY, Rha SW, Li YJ, et al. The impact of high sensitivity C-reactive protein level on coronary artery spasm as assessed by intracoronary acetylcholine provocation test. Yonsei Med J. 2013;54(6):1299–1304. doi:10.3349/ymj.2013.54.6.1299
   PubMed Web of Science ®Google Scholar